2026 NPPES data Hematology & Oncology Physician NPI 1518172782 M.B.B.S
Verify on CMS →

Sani Kizilbash, M.B.B.S

Hematology & Oncology Physician in Rochester, Minnesota.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,530 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
114
Medicare Part D claims · 38 beneficiaries · Hematology & Oncology Physician avg: 885
Generic prescribing
88%
generic claims · 12% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

Sani Kizilbash, M.B.B.S filed 114 Medicare Part D claims in 2024 as a Hematology & Oncology Physician in Rochester, Minnesota, prescribing 88% generic.

114
Part D claims, 2024
88%
generic prescribing
Likely
board-certified (heuristic)
≥34th
pct by Part D claim volume (lower-bound band)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Sani Kizilbash, M.B.B.S

Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1518172782), first enumerated 05/11/2007.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 114 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    Board certification signal

    Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.

    Source: NUCC taxonomy + CMS participation heuristic

  • Reported

    Hospital affiliations

    1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.

    Source: CMS Care Compare

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

CMS NPPES provider registry desk

NPI 1518172782 · Hematology & Oncology Physician

NPI-10 · ENUM-MID · TAX-MID · RX-LIGHT · BOOK-THIN · PHOTO-ENUM

  • NPI-10 1518172782
  • ENUM-MID 2007
  • TAX-MID 12K Hematology &
  • RX-LIGHT 114
  • BOOK-THIN 235 in Minnesota
  • PHOTO-ENUM John Renshaw, M.D. · 2007

Sani Kizilbash, M.B.B.S's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2024, across all CMS prescribers nationally

114 ≥ 34th percentile 34% of 1,416,883 prescribers are in lower value bands

0–200: 679,947 prescribers (48%). This entry sits in this band. 200–400: 188,835 prescribers (13%). Above this entry. 400–600: 95,866 prescribers (7%). Above this entry. 600–800: 60,107 prescribers (4%). Above this entry. 800–1,000: 43,043 prescribers (3%). Above this entry. 1,000–1,200: 33,612 prescribers (2%). Above this entry. 1,200–1,400: 27,889 prescribers (2%). Above this entry. 1,400–1,600: 23,183 prescribers (2%). Above this entry. 1,600–1,800: 19,917 prescribers (1%). Above this entry. 1,800–2,000: 17,585 prescribers (1%). Above this entry. 2K+: 226,899 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.

Source CMS Medicare Part D Prescriber Public Use File · 2024

Board certification likely (heuristic, not verified)

Sani Kizilbash, M.B.B.S practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Sani Kizilbash, M.B.B.S?

Quality data not reported

NPI registry status

Active

Issued 05/11/2007

NPI 1518172782

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,530 US NPIs in this specialty

Medicare Part D claims

114 87% vs specialty avg

2024 prescription claims

Specialty avg: 885

Specialty distribution in Minnesota

How Hematology & Oncology Physician compares to other specialties among Minnesota providers

Minnesota providers
Behavior Technician12%Clinical Social Worker4.7%Physical Therapist4%Pharmacist3.7%Student in an Organized Heal…3.4%Mental Health Counselor3.1%Hematology & Oncology Physic…0.2%
Largest specialties in Minnesota (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Hematology & Oncology Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

200 1ST ST SW
Rochester, MN 55905

Provider Details

NPI 1518172782
Specialty Hematology & Oncology Physician
Credentials M.B.B.S
Gender Male
NPI Issued 05/11/2007

Hospital and facility affiliations

Facilities where Sani Kizilbash, M.B.B.S bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Mayo Clinic
Rochester, MN

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Brand vs generic prescribing mix · Typical

Sani Kizilbash, M.B.B.S - brand share 12.0%
Hematology & Oncology Physician average

12% brand-name claims vs 88% generic, on 114 2024 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

114
Total Claims
$32K
Total Drug Cost
38
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
151.667
Total Day Supply
3,864
Brand vs Generic
12% brand / 88% generic
Brand Drug Cost
$30K
Generic Drug Cost
$1K
Antibiotic Claims
18

Patient Demographics

Average Patient Age
66.6 years
Avg HCC Risk Score
2.41
Gender Split
39% female / 61% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

What Sani Kizilbash, M.B.B.S prescribes most

Top Medicare Part D drugs by claim count, 2024

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2024
Drug Claims
Sulfamethoxazole-Trimethoprim
Sulfamethoxazole/Trimethoprim
18
Ondansetron Hcl
17
Dexamethasone
15

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How Sani Kizilbash, M.B.B.S fits within the Hematology & Oncology Physician landscape nationally.

11,530
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
885
Avg Claims per Provider

Sani Kizilbash, M.B.B.S's 114 claims are below the specialty average of 885.

Nationwide Hematology & Oncology Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Kizilbash, both outside Minnesota so the neighborhoods are not geographic containment.

Same NPPES enumeration year (2007)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Hematology & Oncology Physician Providers in Minnesota

Other clinicians with the same primary specialty enrolled in Minnesota, drawn from the same CMS NPPES roster as Kizilbash.

One of 235 Hematology & Oncology Physician providers enrolled in Minnesota, 5 are shown here.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is Sani Kizilbash, M.B.B.S's specialty?
Sani Kizilbash, M.B.B.S specializes in Hematology & Oncology Physician and practices in Rochester, Minnesota. Credentials: M.B.B.S.
How much does Sani Kizilbash, M.B.B.S prescribe under Medicare Part D?
In 2024, Sani Kizilbash, M.B.B.S wrote 114 Medicare Part D claims totaling $32K in drug costs for 38 beneficiaries.
Where is Sani Kizilbash, M.B.B.S located?
Sani Kizilbash, M.B.B.S is located at 200 1ST ST SW, Rochester, MN, 55905. Phone: (507) 284-2511.
What is Sani Kizilbash, M.B.B.S's NPI number?
Sani Kizilbash, M.B.B.S's National Provider Identifier (NPI) is 1518172782, issued on 05/11/2007.
Does Sani Kizilbash, M.B.B.S prescribe more brand-name or generic drugs?
Sani Kizilbash, M.B.B.S's prescribing is 12% brand-name and 88% generic drugs by claim count, with $30K in brand drug costs.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,530 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 885 Medicare Part D claims per year.
What drugs does Sani Kizilbash, M.B.B.S prescribe most often?
Based on 2024 Medicare Part D data, Sani Kizilbash, M.B.B.S's most frequently prescribed drugs include Sulfamethoxazole-Trimethoprim, Ondansetron Hcl, Dexamethasone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Sani Kizilbash, M.B.B.S accept Medicare?
Sani Kizilbash, M.B.B.S appears in CMS Medicare data with 114 Part D claims and 38 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Sani Kizilbash, M.B.B.S's credentials?
Sani Kizilbash, M.B.B.S's NPI is 1518172782 with credentials M.B.B.S. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.